Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2026 08:22 ET | Source: Spherix Global Insights

Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Announcement at EHA 2026

Exton, PA, June 12, 2026 (GLOBE NEWSWIRE) -- Despite widespread recognition that long-term steroid exposure should be minimized in patients with warm autoimmune hemolytic anemia (w-AIHA), treatment...
June 12, 2026 08:22 ET | Source: Behemoth Labz

Behemoth Labz Introduces Insights Into Growing Demand for COA Tested SARMs and Peptides in Research Applications

LAS VEGAS, NV, USA, June 12, 2026 (GLOBE NEWSWIRE) -- Behemoth Labz has introduced new insights regarding increasing demand for Certificate of Analysis (COA)-tested SARMs and Peptides within...
June 12, 2026 08:18 ET | Source: BCC Research LLC

AI-Driven Genomic Revolution Reshapes $50+ Billion GM Foods Market as Food Security Concerns Intensify

According to BCC Research, AI is helping reduce regulatory uncertainty and accelerate R&D across the genetically modified foods industry.
June 12, 2026 08:10 ET | Source: Equity Insider

After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell

Issued on behalf of GT Biopharma, Inc. Natural killer cells were long overshadowed by T-cell therapies. Now a growing field is trying to unleash them — with the promise of off-the-shelf,...
June 12, 2026 08:00 ET | Source: Profusa, Inc.

Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform

BERKELEY, CA, June 12, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, today announces that it has submitted its...
June 12, 2026 08:00 ET | Source: UniFirst Corporation

UniFirst Shareholders Approve Transaction with Cintas

WILMINGTON, Mass., June 12, 2026 (GLOBE NEWSWIRE) -- UniFirst Corporation (NYSE: UNF) (“UniFirst” or “the Company”) today announced that at its Special Meeting of Shareholders (the “Special...
June 12, 2026 08:00 ET | Source: Echo IQ

Research Collaboration Secured to Evaluate AI-Driven Cardiac Risk Stratification in Cancer Patients

Research collaboration with Mayo Clinic to evaluate EIQ’s AI platform for cardiac risk stratification in oncology patientsStudy to assess the ability of Echo IQ's AI technology to evaluate cardiac...
June 12, 2026 08:00 ET | Source: Cogent Biosciences, Inc.

Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress

-- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an updated objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria – ...
June 12, 2026 07:30 ET | Source: United Community Banks, Inc.

United Community Banks, Inc. Announces Agreement to Sell Equipment Finance Business, Consisting of Navitas Credit Corp. and NLFC Reinsurance Corp., to Funds Managed by Wafra Inc.

GREENVILLE, S.C., June 12, 2026 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (“United”) today announced the execution of a definitive agreement to sell its equipment finance...
June 12, 2026 07:00 ET | Source: Kymera Therapeutics, Inc.

Kymera Therapeutics Presents Phase 1 Data in Healthy Japanese Adults for KT-621, a First-in-Class Oral STAT6 Degrader, at the Japanese Dermatological Association Annual Meeting

Oral presentation at JDA features new data from the KT-621 Phase 1 study in healthy Japanese adults, with safety and PK/PD results consistent with previously reported KT-621 clinical studies KT-621...